Cargando…
Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study
Autor principal: | Longevity, Oxidative Medicine and Cellular |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412365/ https://www.ncbi.nlm.nih.gov/pubmed/37565167 http://dx.doi.org/10.1155/2023/9828565 |
Ejemplares similares
-
Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study
por: Jia, Nina, et al.
Publicado: (2022) -
Retracted: Protective Effects of Soy Oligopeptides in Ultraviolet B-Induced Acute Photodamage of Human Skin
por: Cellular Longevity, Oxidative Medicine and
Publicado: (2020) -
Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
Retracted: DNA Topoisomerase II-α Regulated by miR-22-5p Promotes Hepatocellular Carcinoma Invasion and Migration through the Hippo Pathway
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023) -
Retracted: Active Ingredient Paeonol of Jijiu Huiyang Decoction Alleviates Isoproterenol-Induced Chronic Heart Failure via the GSK3A/PPARα Pathway
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)